The role of extracellular vesicles as a shared disease mechanism contributing to multimorbidity in patients with COPD
The role of extracellular vesicles as a shared disease mechanism contributing to multimorbidity in patients with COPD
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Individuals with COPD typically experience a progressive, debilitating decline in lung function as well as systemic manifestations of the disease. Multimorbidity, is common in COPD patients and increases the risk of hospitalisation and mortality. Central to the genesis of multimorbidity in COPD patients is a self-perpetuating, abnormal immune and inflammatory response driven by factors including ageing, pollutant inhalation (including smoking) and infection. As many patients with COPD have multiple concurrent chronic conditions, which require an integrative management approach, there is a need to greater understand the shared disease mechanisms contributing to multimorbidity. The intercellular transfer of extracellular vesicles (EVs) has recently been proposed as an important method of local and distal cell-to-cell communication mediating both homeostatic and pathological conditions. EVs have been identified in many biological fluids and provide a stable capsule for the transfer of cargo including proteins, lipids and nucleic acids. Of these cargo, microRNAs (miRNAs), which are short 17-24 nucleotide non-coding RNA molecules, have been amongst the most extensively studied. There is evidence to support that miRNA are selectively packaged into EVs and can regulate recipient cell gene expression including major pathways involved in inflammation, apoptosis and fibrosis. Furthermore changes in EV cargo including miRNA have been reported in many chronic diseases and in response to risk factors including respiratory infections, noxious stimuli and ageing. In this review, we discuss the potential of EVs and EV-associated miRNA to modulate shared pathological processes in chronic diseases. Further delineating these may lead to the identification of novel biomarkers and therapeutic targets for patients with COPD and multimorbidities.
COPD - chronic obstructive pulmonary disease, EV - extracellular vesicle, inflammation, miRNA - microRNA, multimorbidity
Reid, Laura V.
72343552-339b-45d8-820b-d12fdb98b027
Spalluto, C. Mirella
6802ad50-bc38-404f-9a19-40916425183b
Watson, Alastair
9eb79329-8d32-4ed4-b8b9-d720883e8042
Staples, Karl J.
e0e9d80f-0aed-435f-bd75-0c8818491fee
Wilkinson, Tom M.A.
8c55ebbb-e547-445c-95a1-c8bed02dd652
2 December 2021
Reid, Laura V.
72343552-339b-45d8-820b-d12fdb98b027
Spalluto, C. Mirella
6802ad50-bc38-404f-9a19-40916425183b
Watson, Alastair
9eb79329-8d32-4ed4-b8b9-d720883e8042
Staples, Karl J.
e0e9d80f-0aed-435f-bd75-0c8818491fee
Wilkinson, Tom M.A.
8c55ebbb-e547-445c-95a1-c8bed02dd652
Reid, Laura V., Spalluto, C. Mirella, Watson, Alastair, Staples, Karl J. and Wilkinson, Tom M.A.
(2021)
The role of extracellular vesicles as a shared disease mechanism contributing to multimorbidity in patients with COPD.
Frontiers in Immunology, 12, [754004].
(doi:10.3389/fimmu.2021.754004).
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Individuals with COPD typically experience a progressive, debilitating decline in lung function as well as systemic manifestations of the disease. Multimorbidity, is common in COPD patients and increases the risk of hospitalisation and mortality. Central to the genesis of multimorbidity in COPD patients is a self-perpetuating, abnormal immune and inflammatory response driven by factors including ageing, pollutant inhalation (including smoking) and infection. As many patients with COPD have multiple concurrent chronic conditions, which require an integrative management approach, there is a need to greater understand the shared disease mechanisms contributing to multimorbidity. The intercellular transfer of extracellular vesicles (EVs) has recently been proposed as an important method of local and distal cell-to-cell communication mediating both homeostatic and pathological conditions. EVs have been identified in many biological fluids and provide a stable capsule for the transfer of cargo including proteins, lipids and nucleic acids. Of these cargo, microRNAs (miRNAs), which are short 17-24 nucleotide non-coding RNA molecules, have been amongst the most extensively studied. There is evidence to support that miRNA are selectively packaged into EVs and can regulate recipient cell gene expression including major pathways involved in inflammation, apoptosis and fibrosis. Furthermore changes in EV cargo including miRNA have been reported in many chronic diseases and in response to risk factors including respiratory infections, noxious stimuli and ageing. In this review, we discuss the potential of EVs and EV-associated miRNA to modulate shared pathological processes in chronic diseases. Further delineating these may lead to the identification of novel biomarkers and therapeutic targets for patients with COPD and multimorbidities.
Text
Reid et al 2021 Front Immunol
- Version of Record
More information
Accepted/In Press date: 4 November 2021
Published date: 2 December 2021
Additional Information:
Funding Information:
This work was funded by an MRC Integrated PhD studentship awarded for LR’s doctoral studies.
Publisher Copyright:
Copyright © 2021 Reid, Spalluto, Watson, Staples and Wilkinson.
Keywords:
COPD - chronic obstructive pulmonary disease, EV - extracellular vesicle, inflammation, miRNA - microRNA, multimorbidity
Identifiers
Local EPrints ID: 452953
URI: http://eprints.soton.ac.uk/id/eprint/452953
ISSN: 1664-3224
PURE UUID: 0819651b-e5eb-4200-bc70-248d978b68d3
Catalogue record
Date deposited: 07 Jan 2022 11:46
Last modified: 17 Mar 2024 03:08
Export record
Altmetrics
Contributors
Author:
Laura V. Reid
Author:
C. Mirella Spalluto
Author:
Alastair Watson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics